{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:53:43Z","timestamp":1790351623704,"version":"4.1.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With progressive accumulation of knowledge on SARS-CoV-2 infection clinical management, treatment guidelines recommended several options including remdesivir, a broad-spectrum antiviral. Given the evolving nature of coronavirus disease 2019, capturing the totality of scientific evidence from clinical trials and observational studies is critical to inform clinical decision making. We conducted a systematic literature review with meta-analysis to summarize the effectiveness of remdesivir among hospitalized adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched MEDLINE, Embase and Cochrane Library databases for interventional and observational studies examining remdesivir efficacy. A rigorous double-reviewer approach was used for source identification, screening, data extraction and risk of bias assessment. A hierarchical random-effects model meta-analysis was used, with subgroup analyses for randomized controlled trials (RCTs) and real-world (RW) studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From January 2019 to December 2023 &amp;gt;18 000 sources were screened, and 122 unique studies were identified, reporting on 25 174 participants in RCTs and 1 279 859 in RW studies. Remdesivir significantly increased survival in the overall population (odds ratio, 0.69 [95% confidence interval, .55\u2013.86]; P = .001] across SARS-CoV-2 variants and disease severity levels: no supplemental oxygen (0.81 [.75\u2013.88]), low-flow oxygen (0.71 [.64\u2013.79]), high-flow oxygen (0.87 [.83\u2013.91]), and invasive mechanical ventilation (0.78 [.68\u2013.90]). Rehospitalization risk was significantly reduced in patients receiving remdesivir (odds ratio, 0.72 [95% confidence interval, .64\u2013.81]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our comprehensive systematic literature review, capturing the totality of evidence, showed a significant survival benefit among patients hospitalized for SARS-CoV-2 infection and receiving remdesivir, across all disease severity levels. To assure that healthcare providers are aware of and deploy evidence-based optimal care, recommendations should rely on both RCT and RW data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf111","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:20:44Z","timestamp":1741652444000},"page":"20-29","source":"Crossref","is-referenced-by-count":21,"title":["A Systematic Review and Meta-analysis of the Effectiveness of Remdesivir to Treat SARS-CoV-2 in Hospitalized Patients: Have the Guidelines Evolved With the Evidence?"],"prefix":"10.1093","volume":"81","author":[{"given":"Michele","family":"Bartoletti","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , Milan ,","place":["Italy"]},{"name":"Infectious Disease Unit, IRCCS Humanitas Research Hospital , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essy","family":"Mozaffari","sequence":"additional","affiliation":[{"name":"Medical Affairs, Gilead Sciences , Foster City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9790-0245","authenticated-orcid":false,"given":"Alpesh N","family":"Amin","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine & Palliative Medicine, University of California Irvine , Irvine, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9620-2525","authenticated-orcid":false,"given":"Yohei","family":"Doi","sequence":"additional","affiliation":[{"name":"Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine , Toyoake, Aichi ,","place":["Japan"]},{"name":"Division of Infectious Diseases, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1218-9432","authenticated-orcid":false,"given":"Paul","family":"Loubet","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Centre Hospitalier Universitaire de N\u00eemes , N\u00eemes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8308-3264","authenticated-orcid":false,"given":"Christina G","family":"Rivera","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roshon","sequence":"additional","affiliation":[{"name":"Department of Quality, UC Health-Southern Region , Colorado Springs, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6962-1006","authenticated-orcid":false,"given":"Aaditya","family":"Rawal","sequence":"additional","affiliation":[{"name":"US Market Access and Health Economics, Costello Medical , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kaiser","sequence":"additional","affiliation":[{"name":"US Literature Reviews, Costello Medical , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vutcovici Nicolae","sequence":"additional","affiliation":[{"name":"Certara Drug Development Solutions, Certara , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Fu","sequence":"additional","affiliation":[{"name":"Certara Drug Development Solutions, Certara , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0095-1679","authenticated-orcid":false,"given":"Thomas F","family":"Oppelt","sequence":"additional","affiliation":[{"name":"Medical Affairs, Gilead Sciences , Foster City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Chiang","sequence":"additional","affiliation":[{"name":"Medical Affairs, Gilead Sciences , Foster City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E","family":"Sax","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6489-6294","authenticated-orcid":false,"given":"Andre C","family":"Kalil","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Nebraska Medical Center , Omaha, Nebraska ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2025080104323404400_ciaf111-B1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12913-022-08975-3","article-title":"Approaches to clinical guideline development in healthcare: a scoping review and document analysis","volume":"23","author":"De Leo","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"2025080104323404400_ciaf111-B2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12955-017-0621-0","article-title":"Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach","volume":"15","author":"Zhang","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"2025080104323404400_ciaf111-B3","author":"Benavidez","year":"2019"},{"issue":"suppl 1","key":"2025080104323404400_ciaf111-B4","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/sj.bjc.6601077","article-title":"Clinical practice guidelines: towards better quality guidelines and increased international collaboration","volume":"89","author":"Grol","year":"2003","journal-title":"Br J Cancer"},{"key":"2025080104323404400_ciaf111-B5","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2020.4742","article-title":"Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics","volume":"323","author":"Kalil","year":"2020","journal-title":"JAMA"},{"key":"2025080104323404400_ciaf111-B6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.47102\/annals-acadmedsg.V47N12p523","article-title":"Making clinical practice guidelines pragmatic: how big data and real world evidence can close the gap","volume":"47","author":"Chew","year":"2018","journal-title":"Ann Acad Med Singap"},{"key":"2025080104323404400_ciaf111-B7","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1016\/S2666-7568(22)00186-6","article-title":"Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43\u2008895 trials and 5\u2008685\u2008738 individuals across 989 unique drugs and 286 conditions in England","volume":"3","author":"Tan","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"2025080104323404400_ciaf111-B8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s11673-020-10045-4","article-title":"Ethical challenges in clinical research during the COVID-19 pandemic","volume":"17","author":"Bierer","year":"2020","journal-title":"J Bioeth Inq"},{"key":"2025080104323404400_ciaf111-B9","doi-asserted-by":"crossref","first-page":"100533","DOI":"10.1016\/j.xcrm.2022.100533","article-title":"Treating COVID-19: evolving approaches to evidence in a pandemic","volume":"3","author":"Lee","year":"2022","journal-title":"Cell Rep Med"},{"key":"2025080104323404400_ciaf111-B10","author":"European Medicines Agency","year":"2020"},{"key":"2025080104323404400_ciaf111-B11","author":"Food and Drug Administration (FDA)","year":"2020"},{"key":"2025080104323404400_ciaf111-B12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.cmi.2022.08.013","article-title":"European Society of Clinical Microbiology and Infectious Diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild\/moderate disease","volume":"28","author":"Bartoletti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025080104323404400_ciaf111-B13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2021.11.007","article-title":"ESCMID COVID-19 living guidelines: drug treatment and clinical management","volume":"28","author":"Bartoletti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025080104323404400_ciaf111-B14","doi-asserted-by":"crossref","first-page":"2100048","DOI":"10.1183\/13993003.00048-2021","article-title":"Management of hospitalized adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline","volume":"57","author":"Chalmers","year":"2021","journal-title":"Eur Respir J"},{"key":"2025080104323404400_ciaf111-B15","author":"Infectious Diseases Society of America","year":"2023"},{"key":"2025080104323404400_ciaf111-B16","author":"National Institutes of Health","year":"2024"},{"key":"2025080104323404400_ciaf111-B17","author":"World Health Organization","year":"2023"},{"key":"2025080104323404400_ciaf111-B18","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025080104323404400_ciaf111-B19","volume-title":"Multinational registries: challenges and opportunities. Addendum to registries for evaluating patient outcomes: a user\u2019s guide","author":"Leavy","year":"2018","edition":"3rd ed"},{"key":"2025080104323404400_ciaf111-B20","author":"University of York, Centre for Reviews and Dissemination","year":"2009"},{"key":"2025080104323404400_ciaf111-B21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"2025080104323404400_ciaf111-B22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2025080104323404400_ciaf111-B23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"2025080104323404400_ciaf111-B24","doi-asserted-by":"crossref","first-page":"e0261142","DOI":"10.1371\/journal.pone.0261142","article-title":"Inpatient COVID-19 mortality has reduced over time: results from an observational cohort","volume":"17","author":"Bechman","year":"2022","journal-title":"PLoS One"},{"key":"2025080104323404400_ciaf111-B25","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"2025080104323404400_ciaf111-B26","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/cid\/ciab536","article-title":"Improved survival among hospitalized patients with coronavirus disease 2019 (COVID-19) treated with remdesivir and dexamethasone. A nationwide population-based cohort study","volume":"73","author":"Benfield","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025080104323404400_ciaf111-B27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/EDE.0000000000001598","article-title":"Effectiveness of remdesivir treatment protocols among patients hospitalized with COVID-19: a target trial emulation","volume":"34","author":"Breskin","year":"2023","journal-title":"Epidemiology"},{"key":"2025080104323404400_ciaf111-B28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/covid3020015","article-title":"Real-world safety and effectiveness of remdesivir and corticosteroids in hospitalized patients with COVID-19","volume":"3","author":"Caffrey","year":"2023","journal-title":"Covid"},{"key":"2025080104323404400_ciaf111-B29","doi-asserted-by":"crossref","first-page":"e2244505","DOI":"10.1001\/jamanetworkopen.2022.44505","article-title":"Association of remdesivir treatment with mortality among hospitalized adults with COVID-19 in the United States","volume":"5","author":"Chokkalingam","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025080104323404400_ciaf111-B30","author":"De Vito"},{"key":"2025080104323404400_ciaf111-B31","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/cid\/ciab698","article-title":"Remdesivir and mortality in patients with coronavirus disease 2019","volume":"74","author":"Diaz","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025080104323404400_ciaf111-B32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcm12062371","article-title":"Retrospective analysis of the effectiveness of remdesivir in COVID-19 treatment during periods dominated by Delta and Omicron SARS-CoV-2 variants in clinical settings","volume":"12","author":"Dobrowolska","year":"2023","journal-title":"J Clin Med"},{"key":"2025080104323404400_ciaf111-B33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.amjms.2022.01.021","article-title":"Association of treatment with remdesivir and 30-day hospital readmissions in patients hospitalized with COVID-19: multicenter study","volume":"363","author":"Finn","year":"2022","journal-title":"Am J Med Sci"},{"key":"2025080104323404400_ciaf111-B34","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1093\/cid\/ciab1035","article-title":"Real-world effectiveness of remdesivir in adults hospitalized with coronavirus disease 2019 (COVID-19): a retrospective, multicenter comparative effectiveness study","volume":"75","author":"Garibaldi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025080104323404400_ciaf111-B35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.26536","article-title":"Fewer COVID-19 neurological complications with dexamethasone and remdesivir","volume":"93","author":"Grundmann","year":"2023","journal-title":"Ann Neurol"},{"key":"2025080104323404400_ciaf111-B36","doi-asserted-by":"crossref","first-page":"ofaa481","DOI":"10.1093\/ofid\/ofaa481","article-title":"Remdesivir use in patients requiring mechanical ventilation due to COVID-19","volume":"7","author":"Lapadula","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025080104323404400_ciaf111-B37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/23744235.2023.2187081","article-title":"Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone","volume":"55","author":"Leding","year":"2023","journal-title":"Infect Dis"},{"key":"2025080104323404400_ciaf111-B38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s15010-022-01841-8","article-title":"Clinical outcomes of hospitalized COVID-19 patients treated with remdesivir: a retrospective analysis of a large tertiary care center in Germany","volume":"51","author":"Marx","year":"2023","journal-title":"Infection"},{"key":"2025080104323404400_ciaf111-B39","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1093\/cid\/ciab875","article-title":"Remdesivir treatment in hospitalized patients with coronavirus disease 2019 (COVID-19): a comparative analysis of in-hospital all-cause mortality in a large multicenter observational cohort","volume":"75","author":"Mozaffari","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025080104323404400_ciaf111-B40","first-page":"218","article-title":"Remdesivir reduces mortality in hospitalized covid-19 patients across variant eras. Conference abstract","volume":"31","author":"Mozaffari","year":"2023","journal-title":"Top Antivir Med"},{"key":"2025080104323404400_ciaf111-B41","doi-asserted-by":"crossref","first-page":"ofab278","DOI":"10.1093\/ofid\/ofab278","article-title":"Remdesivir versus standard-of-care for severe coronavirus disease 2019 infection: an analysis of 28-day mortality","volume":"8","author":"Olender","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025080104323404400_ciaf111-B42","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses","volume":"399","author":"Henao-Restrepo","year":"2022","journal-title":"Lancet"},{"key":"2025080104323404400_ciaf111-B43","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"2025080104323404400_ciaf111-B44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","article-title":"The levels of evidence and their role in evidence-based medicine","volume":"128","author":"Burns","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"2025080104323404400_ciaf111-B45","doi-asserted-by":"crossref","first-page":"e2136263","DOI":"10.1001\/jamanetworkopen.2021.36263","article-title":"Adherence of clinical practice guidelines for pharmacologic treatments of hospitalized patients with COVID-19 to trustworthy standards: a systematic review","volume":"4","author":"Burns","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025080104323404400_ciaf111-B46","doi-asserted-by":"crossref","first-page":"e014188","DOI":"10.1136\/bmjgh-2023-014188","article-title":"Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match","volume":"9","author":"Cokljat","year":"2024","journal-title":"BMJ Glob Health"},{"key":"2025080104323404400_ciaf111-B47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/ciad505","article-title":"Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION network, 10 states, June 2021\u2013March 2023","volume":"78","author":"Griggs","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025080104323404400_ciaf111-B48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/cid\/ciad276","article-title":"Changing severity and epidemiology of adults hospitalized with coronavirus disease 2019 (COVID-19) in the United States after introduction of COVID-19 vaccines, March 2021\u2013August 2022","volume":"77","author":"Kojima","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025080104323404400_ciaf111-B49","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/cid\/ciad655","article-title":"The current mismatch between COVID-19 clinical trial design and the evolving profile of hospitalized patients: a retrospective cohort analysis","volume":"78","author":"Montejano","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025080104323404400_ciaf111-B50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jamainternmed.2022.1906","article-title":"Racial and ethnic discrepancy in pulse oximetry and delayed identification of treatment eligibility among patients with COVID-19","volume":"182","author":"Fawzy","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2025080104323404400_ciaf111-B51","doi-asserted-by":"crossref","first-page":"e2134147","DOI":"10.1001\/jamanetworkopen.2021.34147","article-title":"Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic review and meta-analysis","volume":"4","author":"Magesh","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025080104323404400_ciaf111-B52","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s40615-024-01942-0","article-title":"Racial and ethnic disparities in COVID-19 treatments in the United States","volume":"12","author":"Mozaffari","year":"2025","journal-title":"J Racial Ethn Health Disparities"},{"key":"2025080104323404400_ciaf111-B53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15585\/mmwr.mm7103e1","article-title":"Racial and ethnic disparities in receipt of medications for treatment of COVID-19\u2014United States, March 2020\u2013August 2021","volume":"71","author":"Wiltz","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025080104323404400_ciaf111-B54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jclinepi.2019.10.013","article-title":"Meta-analyses frequently pooled different study types together: a meta-epidemiological study","volume":"118","author":"Bun","year":"2020","journal-title":"J Clin Epidemiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf111\/62377402\/ciaf111.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/1\/20\/62377402\/ciaf111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/1\/20\/62377402\/ciaf111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:33:57Z","timestamp":1754037237000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/1\/20\/8069779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,11]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf111","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,15]]},"published":{"date-parts":[[2025,3,11]]}}}